A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This vital cancer suppressor protein is frequently inactivated in various kinds of cancer, resulting https://webcastlist.com/story23470658/nanobodies-reactivate-p53-new-potential-approach-for-malignant-therapy